Publications by authors named "Pascale Gaillard"

Claim this Profile
P
Posterior urethral valves: how the study of fetal micturition can help to reach the diagnosis?
Solene Quibel, Marie Brasseur-Daudruy, Agnes Liard-Zmuda, Pascale Gaillard, Eric Verspyck

Prenat Diagn· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies.
Philipp Haselmayer, Montserrat Camps, Mathilde Muzerelle, Samer El Bawab, Caroline Waltzinger, Pascale Gaillard

Front Immunol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The p110delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors.
Alex Berndt, Simon Miller, Olusegun Williams, Daniel D Le, Benjamin T Houseman, Pascale Gaillard

Nat Chem Biol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors.
Alex Berndt, Simon Miller, Olusegun Williams, Daniel D Le, Benjamin T Houseman, Pascale Gaillard

Nat Chem Biol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cellular assay for measuring the modulation of glucose production in H4IIE cells.
Anne-Marie de Raemy-Schenk, Solenne Troublé, Pascale Gaillard, Patrick Page, Jean-Pierre Gotteland

Assay Drug Dev Technol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cellular assay for measuring the inhibition of glycogen synthase kinase-3 via the accumulation of beta-catenin in Chinese hamster ovary clone K1 cells.
Karen Yeow, Laurence Novo-Perez, Pascale Gaillard, Patrick Page, Jean-Pierre Gotteland

Assay Drug Dev Technol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase.
Pascale Gaillard, Isabelle Jeanclaude-Etter, Vittoria Ardissone, Steve Arkinstall, Yves Cambet

J Med Chem· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control of death receptor and mitochondrial-dependent apoptosis by c-Jun N-terminal kinase in hippocampal CA1 neurones following global transient ischaemia.
Sonia Carboni, Bruno Antonsson, Pascale Gaillard, Jean-Pierre Gotteland, Jean-Yves Gillon

J Neurochem· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AS601245 (1,3-benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties.
Sonia Carboni, Agnes Hiver, Cedric Szyndralewiez, Pascale Gaillard, Jean-Pierre Gotteland

J Pharmacol Exp Ther· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats.
Chiara Ferrandi, Rossana Ballerio, Pascale Gaillard, Claudio Giachetti, Sonia Carboni

Br J Pharmacol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis